Iron Gate Global Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $313K | Buy |
11,134
+11
| +0.1% | +$293 | 0.03% | 76 |
|
|
2025
Q4 | $277K | Sell |
11,123
-1,597
| -13% | -$40.3K | 0.03% | 82 |
|
|
2025
Q3 | $324K | Sell |
12,720
-5,664
| -31% | -$140K | 0.03% | 76 |
|
|
2025
Q2 | $446K | Buy |
18,384
+5,687
| +45% | +$133K | 0.05% | 52 |
|
|
2025
Q1 | $322K | Buy |
12,697
+10
| +0.1% | +$262 | 0.04% | 64 |
|
|
2024
Q4 | $341K | Buy |
12,687
+1,910
| +18% | +$51.8K | 0.05% | 62 |
|
|
2024
Q3 | $312K | Sell |
10,777
-1,991
| -16% | -$58.1K | 0.05% | 65 |
|
|
2024
Q2 | $360K | Buy |
12,768
+9
| +0.1% | +$248 | 0.06% | 61 |
|
|
2024
Q1 | $353K | Buy |
12,759
+10
| +0.1% | +$277 | 0.06% | 68 |
|
|
2023
Q4 | $367K | Sell |
12,749
-45
| -0.4% | -$1.36K | 0.07% | 66 |
|
|
2023
Q3 | $424K | Buy |
12,794
+7
| +0.1% | +$248 | 0.1% | 51 |
|
|
2023
Q2 | $469K | Sell |
12,787
-194
| -1% | -$7.55K | 0.1% | 54 |
|
|
2023
Q1 | $530K | Buy |
12,981
+7
| +0.1% | +$302 | 0.13% | 50 |
|
|
2022
Q4 | $601K | Sell |
12,974
-1,456
| -10% | -$69.8K | 0.16% | 47 |
|
|
2022
Q3 | $708K | Sell |
14,430
-441
| -3% | -$21.4K | 0.2% | 42 |
|
|
2022
Q2 | $778K | Sell |
14,871
-2,052
| -12% | -$105K | 0.21% | 40 |
|
|
2022
Q1 | $873K | Sell |
16,923
-6,088
| -26% | -$316K | 0.2% | 43 |
|
|
2021
Q4 | $1.27M | Buy |
23,011
+378
| +2% | +$18.7K | 0.3% | 37 |
|
|
2021
Q3 | $965K | Buy |
22,633
+246
| +1% | +$10.9K | 0.26% | 39 |
|
|
2021
Q2 | $876K | Sell |
22,387
-508
| -2% | -$19.8K | 0.25% | 43 |
|
|
2021
Q1 | $829K | Buy |
22,895
+713
| +3% | +$25.3K | 0.26% | 42 |
|
|
2020
Q4 | $816K | Sell |
22,182
-113
| -0.5% | -$4.14K | 0.3% | 35 |
|
|
2020
Q3 | $771K | Buy |
22,295
+7,397
| +50% | +$259K | 0.33% | 38 |
|
|
2020
Q2 | $494K | Sell |
14,898
-652
| -4% | -$22.2K | 0.24% | 50 |
|
|
2020
Q1 | $477K | Sell |
15,550
-479
| -3% | -$16.3K | 0.32% | 38 |
|
|
2019
Q4 | $596K | Buy |
16,029
+9
| +0.1% | +$321 | 0.34% | 37 |
|
|
2019
Q3 | $546K | Buy |
16,020
+9,349
| +140% | +$340K | 0.33% | 39 |
|
|
2019
Q2 | $274K | Sell |
6,671
-9,330
| -58% | -$370K | 0.18% | 52 |
|
|
2019
Q1 | $639K | Buy |
16,001
+1,122
| +8% | +$44.9K | 0.26% | 34 |
|
|
2018
Q4 | $616K | Buy |
14,879
+1,038
| +7% | +$43.1K | 0.46% | 30 |
|
|
2018
Q3 | $579K | Buy |
13,841
+2,515
| +22% | +$96.8K | 0.38% | 30 |
|
|
2018
Q2 | $390K | Buy |
11,326
+1,988
| +21% | +$67.9K | 0.29% | 33 |
|
|
2018
Q1 | $314K | Buy |
9,338
+115
| +1% | +$3.95K | 0.24% | 38 |
|
|
2017
Q4 | $317K | Sell |
9,223
-693
| -7% | -$23.6K | 0.27% | 39 |
|
|
2017
Q3 | $336K | Buy |
+9,916
| New | +$319K | 0.31% | 37 |
|
Other funds holding PFE
VCM
VPM
Iron Gate Global Advisors's PFE Position: Q1 2026 in Review
Iron Gate Global Advisors increased its Pfizer (PFE) stake by 0.1% in Q1 2026, buying an estimated $293 and bringing the position to 11,134 shares worth $313K. The position accounts for 0.03% of the portfolio, ranked #76.
Iron Gate Global Advisors first reported a position in PFE in Q3 2017 and has held it in 35 quarters since. The position peaked at $1.27M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Iron Gate Global Advisors held 11,134 shares of Pfizer worth $313K as of Q1 2026.
- Iron Gate Global Advisors bought 11 Pfizer shares in Q1 2026, an estimated $293.
- Pfizer made up 0.03% of Iron Gate Global Advisors's portfolio in Q1 2026, its #76 holding.
- Iron Gate Global Advisors first reported a position in Pfizer in Q3 2017 and has held it in 35 quarters since.
- Iron Gate Global Advisors's Pfizer position peaked at $1.27M in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Iron Gate Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.